Literature DB >> 3484428

Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor.

D Metcalf, C G Begley, G R Johnson, N A Nicola, M A Vadas, A F Lopez, D J Williamson, G G Wong, S C Clark, E A Wang.   

Abstract

Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) was purified to homogeneity from medium conditioned by COS cells transfected with a cloned human GM-CSF cDNA and shown to be an effective proliferative stimulus in human marrow cultures for GM and eosinophil colony formation. The specific activity of purified rH GM-CSF in human marrow cultures was calculated to be at least 4 X 10(7) U/mg protein. Clone transfer experiments showed that this proliferation was due to direct stimulation of responding clonogenic cells. Acting alone, rH GM-CSF did not stimulate erythroid colony formation, but in combination with erythropoietin, increased erythroid and multipotential colony formation in cultures of peripheral blood cells. rH GM-CSF had no proliferative effects on adult or fetal murine hematopoietic cells, did not induce differentiation in murine myelomonocytic WEHI-3B cells, and was unable to stimulate the survival or proliferation of murine hematopoietic cell lines dependent on murine multi-CSF (IL 3). rH GM-CSF stimulated antibody-dependent cytolysis of tumor cells by both mature human neutrophils and eosinophils and increased eosinophil autofluorescence and phagocytosis by neutrophils. From a comparison of these effects with those of semipurified preparations of human CSF alpha and -beta, it was concluded that rH GM-CSF exhibited all the biologic activities previously noted for CSF alpha.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484428

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  66 in total

Review 1.  Mechanism of GM-CSF stimulation of neutrophils.

Authors:  R G Coffey
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

3.  Combined effect of protein fusion and signal sequence greatly enhances the production of recombinant human GM-CSF in Escherichia coli.

Authors:  Palash Bhattacharya; Gaurav Pandey; Poonam Srivastava; Krishna Jyoti Mukherjee
Journal:  Mol Biotechnol       Date:  2005-06       Impact factor: 2.695

4.  Localization of the interleukin-3 gene to rat chromosome 10 by linkage analyses with a variable number of tandem repeats (VNTR).

Authors:  T Kunieda; E Kobayashi; M Tachibana; H Ikadai; T Imamichi
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

5.  Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes.

Authors:  M A Arnaout; E A Wang; S C Clark; C A Sieff
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Identification and cellular distribution of distinct proteins forming human GM-CSF receptor.

Authors:  S Chiba; K Shibuya; Y F Piao; A Tojo; N Sasaki; S Matsuki; K Miyagawa; K Miyazono; F Takaku
Journal:  Cell Regul       Date:  1990-03

7.  Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team.

Authors:  D Hardy; S Spector; B Polsky; C Crumpacker; C van der Horst; G Holland; W Freeman; M H Heinemann; G Sharuk; J Klystra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

8.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.

Authors:  G C Bagby; C A Dinarello; R C Neerhout; D Ridgway; E McCall
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.

Authors:  Marcos Oggero; Ronald Frank; Marina Etcheverrigaray; Ricardo Kratje
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.